2Matsubara E, Shoji M, Abe K, et al. Vascular amyloidosis in neurodegenerative condition[J]. Drugs News Perspect,2002,15:439-444.
3Shinkai Y, Yoshimura M, Ito Y, et al. Amyloid beta-protein 1 - 40 and 1 - 42 in the soluble fraction of extra- and intracranial blood vessels[J]. Ann Neurol, 1995,38,421-428.
4Khalil Z, Chen H, Helme RD. Mechanisms underlying the vascular activity of beta-amyloid protein fragment at the level of skin microvasculature[J]. Brain Res, 1996,736:206.
6Hendriks L, Van Duijin CM,Cras P, et al. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the betaamyloid precursor protein gene [ J ]. Nature Genet, 1992,1 : 218-221.
7Nilsberth C, Forsell C, Axelman K, et al. A novel APP mutation -the Arctic mutation-causing Alzheimer' s disease with vascular symptoms[J]. Soc Neurosci, 1999,25 : 120-124.
8Natte R, Mattt MLC, Haan J, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibfillary tangles[ J]. Ann Neurol, 2001,50: 765-772.
9Grabowski TG, Cho HS, Vonsattal JP, et al. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy[J]. Ann Neurol,2001,49:697-705.
10Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloidal Bri deposition and its association with neurofibrillary degeneration in familial British dementia[J]. Am J Pathol,2001,158:515-526.
同被引文献27
1Oddo S,Billings L,Kesslak JP,et al.A beta immunotherapy leads to clearance of early,but not late,hyperphosphorylatedtau aggregates via the proteasome[J].Neuron,2004,43(3):321.
2Weller RO,Massey A,Kuo YM,et al.Cerebral amyloid angiopathy:accumulation of a beta in interstitial fluid drainage pathways in Alzheimer's disease[J].Ann NY Acad Sci,2000,903(1):110.
3Suo Z,Tan J,Placzek A,et al.Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells:the roles of cytokines and CD40[J].Brain Res,1998,807(1-2):110.
4Blennew K.Cerebroepinal fluid protein biomarkers for Alzheimer's disease[J].Neuroboid Aging,2004,25(4):685.
6Hansson O,Zetterberg H,Buchhave P,et al.Association between CSF biomarkers and impairment:a follow-up[J].Lancet Neurol,2006,5(1):228.
7Levey A,Lah J,Goldstein F,et al.Mild cognitive impairment:an opportunity to identify patients at high risk for progression to Alzheimer's disease[J].Clin Ther,2006,28(4):991.
8Richartz E,Stransky E,Ratra A,et al.Decline of immune responsiveness:a pathogenetic factor in Alzheimer's disease?[J].J Psychiatric Res,2005,39 (5):535.
9Monsonego A,Zota V,karni A,et al.Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease[J].J Clin Invest,2003,112(3):415.
10Veerhuis R,Jnassen I,De Groot CJ,et al.Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins,but not C1-inhibitor[J].Exp Neurol,1999,160(1):289.
